OPKO Health Issues Release with Details of Lagova Phase II Clinical Study Presented During Tuesday Webcast

OPKO Health, Inc. (NYSE: OPK), a multinational biopharmaceutical and diagnostics company, yesterday hosted a webcast presenting ...